Table 2: Summary of manoeuvres, effectiveness, level of evidence and recommendations for screening for gestational diabetes | |||
Manoeuvre | Effectiveness | Level of evidence | Recommendation |
Search for risk factors* at the first visit and test for glycosuria at each visit. If result is positive do fasting and postprandial glucose tolerance tests (GCTs) | Effectiveness not evaluated | Expert opinion [35] and case series [36] (III) | Poor evidence to include in periodic health examination of pregnant women (C) |
50-g 1-hour GCT at 28 weeks' gestation | Effectiveness of universal screening not evaluated. Screening may result in decreased incidence of macrosomia and birth trauma. Important questions persist about the significance of mild elevations in the blood glucose level and the benefit of treatment | Cohort study [45] (II), case series [47-50] (III) and uncontrolled trial [52] (II) | Poor evidence to include in periodic health examination of pregnant women (C) |
Measurement of fasting and random blood glucose levels | Sensitivity and specificity not properly evaluated. Women with an abnormal fasting glucose level are more likely than others to benefit from intervention | Case series [2,3,43] (III) | Poor evidence to include in periodic health examination of pregnant women (C) |
*Risk factors for gestational diabetes are obesity, history of miscarriage or fetal death, age 40 years or more, family history of diabetes, polyhydramnios, history of premature infant or infant with macrosomia or congenital malformation, pre-eclampsia, excessive weight gain and glycosuria. |